What is the drug of choice in septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug of Choice in Septic Shock

Norepinephrine is the first-choice vasopressor for septic shock, with a strong recommendation (Grade 1B) from the Surviving Sepsis Campaign guidelines. 1

Initial Management Algorithm

Fluid Resuscitation First

  • Administer at least 30 mL/kg of crystalloids in the first 3 hours before or concurrent with vasopressor initiation 1, 2
  • Crystalloids are the fluid of choice (strong recommendation, moderate quality evidence) 1
  • Do not delay norepinephrine if profound hypotension exists—early vasopressor administration improves cardiac output, microcirculation, and avoids fluid overload 3

Norepinephrine Administration

  • Start norepinephrine as the first-line vasopressor immediately when hypotension persists after initial fluid resuscitation 1, 4
  • Target mean arterial pressure (MAP) of 65 mmHg initially (Grade 1C) 1
  • Administer through central venous access whenever possible 4, 2
  • Place arterial catheter for continuous blood pressure monitoring as soon as practical 1, 4

Escalation Protocol for Refractory Hypotension

Second-Line Agent: Vasopressin

  • Add vasopressin at 0.03 units/minute (not higher) when norepinephrine alone fails to achieve MAP target 1, 4, 2
  • Vasopressin acts on V1 receptors (different pathway than norepinephrine's alpha-1 receptors), providing complementary vasoconstriction 2
  • Never use vasopressin as monotherapy—it must be added to norepinephrine 1, 4
  • Doses above 0.03-0.04 units/minute cause cardiac, digital, and splanchnic ischemia and should only be used for salvage therapy 1, 2

Third-Line Agent: Epinephrine

  • Add epinephrine (0.05-2 mcg/kg/min) when additional vasopressor support is needed beyond norepinephrine plus vasopressin 1, 4, 5
  • Epinephrine can be added to or potentially substituted for norepinephrine (Grade 2B) 1
  • Consider epinephrine earlier if myocardial dysfunction is present with persistent hypoperfusion 1

Inotropic Support

  • Add dobutamine (up to 20 mcg/kg/min) if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident 1, 4, 2

Agents to Avoid

Dopamine

  • Use dopamine ONLY in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia (Grade 2C) 1, 4
  • Dopamine is associated with higher mortality and more arrhythmias compared to norepinephrine 4, 2, 6
  • Never use low-dose dopamine for "renal protection"—this is strongly contraindicated (Grade 1A) 1, 2

Phenylephrine

  • Phenylephrine is not recommended except in three specific circumstances (Grade 1C): 1, 4
    • Norepinephrine causes serious arrhythmias
    • Cardiac output is documented to be high with persistently low blood pressure
    • Salvage therapy when all other agents have failed
  • Phenylephrine may raise blood pressure on the monitor while actually worsening tissue perfusion through excessive vasoconstriction 4

Critical Monitoring Requirements

  • Monitor MAP continuously with arterial catheter 1, 4
  • Assess tissue perfusion markers beyond blood pressure: lactate clearance, urine output, mental status, capillary refill, skin perfusion 1, 2
  • Watch for signs of excessive vasoconstriction: digital ischemia, decreased urine output, rising lactate despite adequate MAP 4

Common Pitfalls to Avoid

  • Do not delay norepinephrine waiting for "complete" fluid resuscitation in profoundly hypotensive patients—early administration improves outcomes 3
  • Do not escalate norepinephrine indefinitely—add vasopressin when norepinephrine requirements remain elevated 4, 2, 7
  • Do not use vasopressin doses above 0.03-0.04 units/minute except as rescue therapy 1, 2
  • Do not use dopamine as first-line therapy—it increases mortality compared to norepinephrine 4, 2, 6

Adjunctive Therapy for Refractory Shock

  • Consider hydrocortisone 200 mg/day if hypotension remains refractory to vasopressors after adequate fluid resuscitation 4, 2
  • Norepinephrine doses above 15 mcg/min (or approximately 0.2 mcg/kg/min in a 70 kg patient) indicate severe shock with mortality rates exceeding 80% 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Septic Shock in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vasopressors to treat refractory septic shock.

Minerva anestesiologica, 2020

Related Questions

In a septic patient with hypotension refractory to adequate fluid resuscitation, what is the first‑line vasopressor, its initial dosing and titration to maintain MAP ≥65 mmHg, and which additional agents should be added if the MAP goal is not achieved?
What is the 2nd line vasopressor agent for septic shock after noradrenaline (norepinephrine)?
What is the recommended use and dosage of Levophed (norepinephrine) in patients with severe hypotension or septic shock?
What is the best second vasopressor to add to norepinephrine (Levophed) for a patient with septic shock and hypotension?
What is the recommended dosing, titration, and dilution protocol for norepinephrine (vasopressor) in managing severe hypotension or septic shock?
What is the recommended dual antiplatelet therapy (DAPT) regimen for 1 year, followed by single antiplatelet therapy, for a patient with single vessel disease who has undergone percutaneous coronary intervention (PCI)?
What is the recommended treatment for a patient with a high Hepatitis B Virus (HBV) DNA viral load of 670?
Is single antiplatelet therapy (SAPT) lifelong after completing dual antiplatelet therapy (DAPT) for one year in patients with ischemic heart disease (IHD) and single vessel disease who have undergone percutaneous coronary intervention (PCI)?
Is there a specific gene associated with subacute sclerosing panencephalitis (SSPE)?
How to measure urine output in a patient who is not on a (urinary) catheter?
What is the management protocol for cardiogenic shock, including the role of coronary angiography?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.